ADCBiologicstaleMacroGenicsPhase 2
vobramitamab duocarmazine (vobramitamab duocarmazine)
Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Cancer · Advanced Solid Tumor
#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 45.8%임상시험 3상태 DISCONTINUED